CytomX Therapeutics, Inc.
CTMX· Nasdaq
CytomX Therapeutics, Inc.
- Last sale
- Oct 2, 2026 · -2.86%
- Market cap
- $555.64M
- 217.9M shares
- Filings
- 796
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $76,201,000 | reported | |
| FY 2024 | 2024-12-31 | $138,103,000 | reported | |
| FY 2023 | 2023-12-31 | $101,214,000 | reported | |
| FY 2022 | 2022-12-31 | $53,163,000 | reported | |
| FY 2021 | 2021-12-31 | $37,312,000 revised | reported | |
| FY 2020 | 2020-12-31 | $68,427,000 revised | reported | |
| FY 2019 | 2019-12-31 | $26,902,000 revised | reported | |
| FY 2018 | 2018-12-31 | $59,502,000 | reported | |
| FY 2017 | 2017-12-31 | $71,623,000 | reported | |
| FY 2016 | 2016-12-31 | $12,845,000 revised | reported | |
| FY 2015 | 2015-12-31 | $7,712,000 | reported | |
| FY 2014 | 2014-12-31 | $5,077,000 | reported |
CytomX Therapeutics, Inc. · CIK 1501989 · Engraved from SEC EDGAR
